Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05401305
What this trial is testing

Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b

Who this might be right for
Haemophilus Influenzae InfectionVaccines
St. Petersburg Research Institute of Vaccines and Sera 60
Not applicableUnknownNCT02257645
What this trial is testing

Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks

Who this might be right for
DiphtheriaTetanusPertussis+2 more
LG Life Sciences 3,000
Post-approval studies (Phase 4)UnknownNCT00877357
What this trial is testing

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Shantha Biotechnics Limited 3,000
Testing effectiveness (Phase 2)Study completedNCT00831311
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 624
Large-scale testing (Phase 3)Study completedNCT06413121
What this trial is testing

Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Who this might be right for
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd. 1,557
Large-scale testing (Phase 3)Study completedNCT01470287
What this trial is testing

Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Novartis Vaccines 175
Post-approval studies (Phase 4)Study completedNCT01404962
What this trial is testing

Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

Who this might be right for
Haemophilus Influenzae Type B Infection
Novartis Vaccines 764
Large-scale testing (Phase 3)Study completedNCT05457946
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 60
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Large-scale testing (Phase 3)Study completedNCT00907777
What this trial is testing

Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 52
Post-approval studies (Phase 4)Study completedNCT01896596
What this trial is testing

Hepatitis B Vaccination in Infants

Who this might be right for
Meningococcal DiseasePneumococcal DiseaseHaemophilus Influenzae Serotype b Disease+2 more
Public Health England 300
Large-scale testing (Phase 3)Study completedNCT00332566
What this trial is testing

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

Who this might be right for
Hepatitis BWhole Cell PertussisTetanus+2 more
GlaxoSmithKline 148
Large-scale testing (Phase 3)Study completedNCT00317109
What this trial is testing

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 168
Large-scale testing (Phase 3)Study completedNCT03891758
What this trial is testing

Confirmatory Study of BK1310 in Healthy Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Tanabe Pharma Corporation 267
Post-approval studies (Phase 4)Study completedNCT00753649
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Who this might be right for
Hepatitis BTetanusPoliomyelitis+3 more
GlaxoSmithKline 224
Early research (Phase 1)Study completedNCT01657526
What this trial is testing

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

Who this might be right for
Respiratory Disorders
GlaxoSmithKline 48
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Large-scale testing (Phase 3)Study completedNCT02428491
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 354
Testing effectiveness (Phase 2)Study completedNCT03443427
What this trial is testing

Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine

Who this might be right for
Respiratory Disorders
GlaxoSmithKline 200
Large-scale testing (Phase 3)Study completedNCT02992925
What this trial is testing

Phase 3 Study of BK1310 in Healthy Infants

Who this might be right for
Immunization; Infection
Tanabe Pharma Corporation 370
Next Page